DOC PREVIEW
UIC PCOL 425 - LECTURE NOTES

This preview shows page 1-2-3-4-5-6 out of 18 pages.

Save
View full document
View full document
Premium Document
Do you want full access? Go Premium and unlock all 18 pages.
Access to all documents
Download any document
Ad free experience
View full document
Premium Document
Do you want full access? Go Premium and unlock all 18 pages.
Access to all documents
Download any document
Ad free experience
View full document
Premium Document
Do you want full access? Go Premium and unlock all 18 pages.
Access to all documents
Download any document
Ad free experience
View full document
Premium Document
Do you want full access? Go Premium and unlock all 18 pages.
Access to all documents
Download any document
Ad free experience
View full document
Premium Document
Do you want full access? Go Premium and unlock all 18 pages.
Access to all documents
Download any document
Ad free experience
View full document
Premium Document
Do you want full access? Go Premium and unlock all 18 pages.
Access to all documents
Download any document
Ad free experience
Premium Document
Do you want full access? Go Premium and unlock all 18 pages.
Access to all documents
Download any document
Ad free experience

Unformatted text preview:

Effects ofEffects ofAdrenergicAdrenergicDrugs Depend on:Drugs Depend on:1) Expression of the receptor (type and number) in 1) Expression of the receptor (type and number) in a specific tissue/organ (i.e.,a specific tissue/organ (i.e.,brochialbrochialsmooth smooth muscle has muscle has ββ22receptors only)receptors only)2) The affinity of the drug for a2) The affinity of the drug for aspecif adrenergicspecif adrenergicreceptor (i.e., NE=receptor (i.e., NE=α α >>β1β1))3) Indirect or reflex effects (i.e., NE decrease HR)3) Indirect or reflex effects (i.e., NE decrease HR)4) Know: receptor expression and affinity 4) Know: receptor expression and affinity for the drug = predict effect in most cases.for the drug = predict effect in most cases.α1α1RRβ1β1RRβ2β2RRα2α2RRβ2β2RRSynthesisBlockersBlockersAmphetamineCocaineCocaineMetyrosineMetyrosineReserpineReserpineGuanethidineGuanethidineBretyliumBretyliumUptake 1Uptake 2MAOPhenelzinePhenelzineStorageSecretionDA TransportClonidineNE,EpiNEEpiHOHOCOHHCH2NCH3HEpinephrineHOOHHOCHHCNH2DopaCOTyrosineHydrolase(limiting step)HOHOCHHCNH2DopamineHDopamineDecarboxylaseHOHOCOHHCNH2NorepinephrineHDopamineβ-HydroxylasePhenylethanolamineN-methyltransferaseNENE-->>αα1/2>1/2>ββ1> 1> ββ22EpiEpi--> > ββ1/2>1/2>αα1/21/2DADA-->D1/2>>>D1/2>>ββ1>>1>>ααCH(CH3)2Isoproterenolααββββact.act.MAOMAOOHHOHHCNH2TyrosineCOC1236αα&&ββact.act.COMTCOMT54MAOMAO* Substitutions at the * Substitutions at the ααcarbon block MAO and prolong actioncarbon block MAO and prolong action(i.e. Ephedrine and Amphetamine)(i.e. Ephedrine and Amphetamine)* OH* OH--on C3 and C5 increase on C3 and C5 increase ββ2 selectivity 2 selectivity HO-5HO-4HOHHCNH2Norepinephrine126CHO-3Hααββββact.act.* Large alkyl substitutions of the NH* Large alkyl substitutions of the NH22increase increase ββand decrease and decrease ααactivity activity (i.e.(i.e.IsoproterenolIsoproterenol). ). ββ22--specific drugs have large substitutionsspecific drugs have large substitutionsαα&&ββact.act.COMTCOMT* Substitutions of OH* Substitutions of OH--C3 and/or C4 decrease activity, but also C3 and/or C4 decrease activity, but also decreasesdecreasesmetabolizationmetabolizationby COMT increasingby COMT increasingbioavailabilitybioavailability(i.e.(i.e.PhenylephrinePhenylephrine).).* Substitutions at the * Substitutions at the ββcarbcarb. decrease CNS but increase . decrease CNS but increase agonist agonist actionactionEpinephrineDopamineNorepinephrineα1/2Rβ1/2RDARNENE-->>αα1/2>1/2>ββ1> 1> ββ22EpiEpi--> > ββ1/2>1/2>αα1/21/2DADA-->D1/2>>D1/2>ββ1>>1>>ααα1RSmooth muscle contractionSmooth muscle contractionBlood vessels:vasoconst.Iris radial musc:->mydriasisSkin: pilomotor musc.α2RPresynapticPresynapticTerminalsTerminalsdecrease NE releasedecrease NE releasePostsynapticPostsynapticTerminalsTerminalsCNS, multipleCNS, multiplePlatelet aggregationPlatelet aggregationβ1RHEARTHEARTIncrease: contraction, HR, output, conductionβ2RSmoothSmoothmuscmusc. relaxation. relaxationLUNG & UTERUSLUNG & UTERUSβ3RLipolysisLipolysisandandThermogenesisThermogenesisSmoothSmoothmuscmusc.relaxation.relaxationRENAL & RENAL & SPLANCHNICSPLANCHNICβ1RHEARTHEARTIncrease: contraction, HR, output, conductionEffectEffectββ11ReceptorReceptorDrug ConcentrationDrug Concentration100%100%50%50%0%0%100%100%50%50%0%0%αα11ReceptorReceptorEpiEpiNENENENEEpiEpiDADA1001005050β1StartStartStartStartStartStartStartStartStopStopStopStopStopStopStopStopHeart RateHeart Rate1801806060Blood Blood PressurePressure120120SPSPMAPMAPDPDPSPSPMAPMAPDPDPSPSPMAPMAPDPDPMAPMAPSPSPDPDPβ1β1beats/beats/minminmm Hgmm HgPeripheralPeripheralResistanceResistanceα1β2β2D1ReflexReflexBradycBradyc..NE NE (10mg/min)(10mg/min)EPI EPI (10mg/min)(10mg/min)IsoprotIsoprot. . (10mg/min)(10mg/min)Dopamine Dopamine (10mg/min)(10mg/min)α11001005050StartStartStopStopHeart RateHeart Rate1801806060Blood Blood PressurePressure120120SPSPMAPMAPDPDPbeats/beats/minminmm Hgmm HgPeripheralPeripheralResistanceResistanceReflexReflexBradycBradyc..NE NE (10mg/min)(10mg/min)αα1 1 receptors in vascular receptors in vascular smooth muscle= vasoconstrictionsmooth muscle= vasoconstrictionVasomotorCenterCenterNucleusNucleusTractusTractusSolitariusSolitariusInhibitoryInhibitoryNeuronNeuronAutonomicAutonomicGangliaGangliaNENENENEAChAChMotorMotorNucleusNucleusVagusVagusBaroreceptorsBaroreceptors( res( responponse to se to chanchanges ges in MAPin MAPAChAChAChACh↓ ↓ HRHRNENEAChAChNENEExcitatory NeuronExcitatory Neuron1001005050β1StartStartStopStopHeart RateHeart Rate1801806060Blood Blood PressurePressure120120SPSPMAPMAPDPDPbeats/beats/minminmm Hgmm HgPeripheralPeripheralResistanceResistanceβ2EPI EPI (10mg/min)(10mg/min)HRHRCOCOβ2Low DosesLow DosesHigh DosesHigh Dosesα1SA node & Atria:SA node & Atria:Rate Rate ContractilityContractilityAutomaticityAutomaticityVelocVeloc. Conduct.. Conduct.AV node & AV node & Conduction:Conduction:Velocity conduction Velocity conduction Effect. Refract. PeriodEffect. Refract. PeriodVentriculeVentricule::Contractility Work Contractility Work O2 consumption Efficiency O2 consumption Efficiency β2α1α11001005050Heart RateHeart Rate1801806060Blood Blood PressurePressure120120beats/beats/minminmm Hgmm HgPeripheralPeripheralResistanceResistanceβ2β1StartStartStopStopSPSPMAPMAPDPDPβ1β2Isoproterenol Isoproterenol StartStartStopStopSPSPMAPMAPDPDPβ1D1D1Renal/Renal/SplachnicSplachnicDopamineDopamineHRHRHRHRCOCOHigher DosesHigher DosesSkeletalSkeletalmuscmusc..COCOHEART: Most effects are HEART: Most effects are ββ11ElecticalElectical:Increase in Rate,:Increase in Rate,AutomaticityAutomaticity,,VelocVeloc. Conduct..; . Conduct..; Decrease in Effect. Refract. PeriodDecrease in Effect. Refract. PeriodMechanical: Increase contractility, CO, work and O2 consumptionMechanical: Increase contractility, CO, work and O2 consumptionBLOOD VESSELS: Depends on theBLOOD VESSELS: Depends on theagonistagonistand vascular bedand vascular bedSkin/MucousSkin/Mucousmembmembα α −−>>VasoconstVasoconst..SplanchnicSplanchnicα α −−>>VasoconstVasoconst. D1 . D1 −−>>vasodilatvasodilat..SkeletalSkeletalmuscmusc..α α −−>>VasoconstVasoconst. . ββ2 2 −−>>vasodilatvasodilat..VenoseVenoseToneToneα α −−>>VasoconstVasoconst. . ββ2 2 −−>>vasodilatvasodilat..Respiratory Tract: Respiratory Tract: ββ2 in bronchia and 2 in bronchia and αα1 in vessels1 in


View Full Document

UIC PCOL 425 - LECTURE NOTES

Documents in this Course
Exam 3

Exam 3

7 pages

Kozasa

Kozasa

14 pages

Load more
Download LECTURE NOTES
Our administrator received your request to download this document. We will send you the file to your email shortly.
Loading Unlocking...
Login

Join to view LECTURE NOTES and access 3M+ class-specific study document.

or
We will never post anything without your permission.
Don't have an account?
Sign Up

Join to view LECTURE NOTES 2 2 and access 3M+ class-specific study document.

or

By creating an account you agree to our Privacy Policy and Terms Of Use

Already a member?